Increasing sleep disorders

The value of the global market for sleep aids was an estimated USD 25 billion in 2009, and is expected to increase to more than USD 33 billion in 2014, at a five-year compound annual growth rate (CAGR) of 5.8 percent. The largest segment of the market, mattresses and pillows, is projected to increase at a CAGR of 3.3 percent, rising to nearly USD 12.5 billion in 2014, after being valued at nearly USD 10.6 billion in 2009. The second-largest segment, sleep laboratories, is estimated at USD 6.7 billion in 2009, and is expected to increase at a CAGR of 6.5 percent to reach more than USD 9.2 billion in 2014. The medications segment is expected to reach USD 7.7 billion in 2014, after rising at a CAGR of 8.3 percent from its 2009 value of nearly USD 5.2 billion. The smallest segment, sleep apnea devices, was valued at nearly USD 2.6 billion in 2009, and is projected to increase to nearly USD 3.8 billion in 2014, at a CAGR of 7.8 percent. Due to the stressors of modern-day life, sleep disorders are a growing health concern. Several factors can influence the quality and quantity of both sleep and rest. These factors include comfort level, anxiety or stress, environment, lifestyle, hormones, nutrition and diet, medications and drugs, and developmental stage.

A growing global market for ophthalmic devices, diagnostics, and surgical equipment

The value of the global market for ophthalmic devices, diagnostics, and surgical equipment was an estimated USD 15.2 billion in 2009, and is expected to increase to more than USD 19 billion in 2014, at a five-year compound annual growth rate (CAGR) of 4.6 percent. The largest segment of the market, contact lenses, is projected to increase at a CAGR of 3.3 percent, rising to more than USD 7.7 billion in 2014, after being valued at nearly USD 6.6 billion in 2009. The second-largest segment, the ophthalmic surgical market, is estimated at USD 5.5 billion in 2009, and is expected to increase at a CAGR of 5.9 percent to reach more than USD 7.3 billion in 2014. The ophthalmic diagnostics segment is expected to reach USD 4 billion in 2014, after rising at a CAGR of 5.2 percent from its 2009 value of nearly USD 3.1 billion. The ageing of the population around the world will result in a rapid increase in the 65 and above population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals, and higher awareness through education. The industry is likely to experience a burst of new products and heavy competition as the ophthalmic market advances.